Delivery Order SPE2DB22D2214-SPE2DB25FS3GE
Award Date
1/6/25
Potential Completion Date
1/7/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has a ceiling value of $1,022.38 and a performance period through April 1, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded a $10,418.24 firm-fixed price delivery order to Amerisourcebergen Drug Corporation's Corporate Office division for the supply of XULANE 150-35 MCG/DAY PATCH 3S. This delivery order was placed against an existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide XULANE 150-35 MCG/DAY PATCH 3S, a specialty pharmaceutical product, with a potential value of $2,113.22 and a completion date of February 2, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a potential value of $1,292.21 and a completion date of February 13, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a potential value of $1,252.68 and a completion date of February 27, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp to deliver...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,296.71 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to supply the XULANE 150-35 MCG/DAY PATCH 3S medical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,169.82 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has a potential value of $2,347.00 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. This award is part of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,145.65 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive medication. The contract has an ultimate completion date of November 12, 2024. This award is a part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $2,961.40 firm fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The order is for XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive medication, and has an ultimate completion date of May 8, 2024. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which serves...